Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|170|2|179-184

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.170, Iss.2, 2015-07, pp. : 179-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bladder Carcinoma after ABVD Chemotherapy for Hodgkin’s Lymphoma: A Case Report

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-03 ,pp. : 148-153

Karger

Access to resources Recommend Favorite

Phase II trial of ofatumumab plus ESHAP (O‐ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first‐line chemotherapy

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 174, Iss. 6, 2016-09 ,pp. : 859-867

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategy

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 689-700

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk and outcome of non‐Hodgkin lymphoma among classical Hodgkin lymphoma survivors

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3385-3392

John Wiley & Sons Inc

Access to resources Recommend Favorite

Obesity negatively impacts outcome in elderly female patients with aggressive B‐cell lymphomas treated with R‐CHOP: results from prospective trials of the German high grade non‐Hodgkin's lymphoma trial group

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 2, 2018-01 ,pp. : 236-245

John Wiley & Sons Inc

Access to resources Recommend Favorite